-
Brain-Computer Interface Lets Non-Verbal People Speak With Thoughts
-
Algae-Powered Microbots Could Revolutionize Bladder Cancer Treatment
-
Metal-Free Carbon Monoxide Prodrug May Stop Cancer Spread
-
Chronic Pancreatitis Hurts More Than Just the Body, Study Finds
-
MIT’s AR Ultrasound System Makes Medical Scans Easier to Read
-
First Guideline on Cardiovascular-Kidney-Metabolic Syndrome
Two leading cardiology organizations have issued the first clinical guidelines specifically targeting cardiovascular-kidney-metabolic syndrome, a condition whose risk factors affect nearly 9 in 10 American adults. The new framework emphasizes earlier screening, lifestyle intervention, and coordinated care to head off serious complications.
-
Extreme Temperatures Are a Growing Heart Health Threat
-
AI Blood Test Could Predict Diabetic Eye Damage Early
-
New RET-Targeted Approach Detects and Treats Aggressive Prostate Cancer
-
Teclistamab Doubles Remission Rates in Relapsed Multiple Myeloma Trial
A major international clinical trial shows the immunotherapy teclistamab dramatically outperforms standard treatments for patients whose multiple myeloma has returned. Nearly two-thirds of patients achieved complete remission, and many showed no detectable cancer on the most sensitive available tests.